International Journal of Antimicrobial Agents
Volume 36, Issue 2 , Pages 129-131 , August 2010

Antimicrobial activity of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia

  • Nicola C. Gordon

      Affiliations

    • Division of Infection, Barts & The London NHS Trust, London, UK
    • ,
  • David W. Wareham

      Affiliations

    • Division of Infection, Barts & The London NHS Trust, London, UK
    • Centre for Immunology and Infection, Blizard Institute of Cell and Molecular Science, Barts & The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
    • Corresponding Author InformationCorresponding author. Present address: Centre for Immunology and Infection, Blizard Institute of Cell and Molecular Science, 4 Newark Street, Whitechapel, London E1 2AT, UK. Tel.: +44 20 7882 2317; fax: +44 20 7882 2181.

Received 5 March 2010 ,Accepted 17 March 2010.

References 

  1. Denton M, Kerr K. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev. 1998;11:57–80
  2. Rogues AM, Maugein J, Allery A, Fleureau C, Boulestreau H, Surcin S, et al. Electronic ventilator temperature sensors as a potential source of respiratory tract colonization with Stenotrophomonas maltophilia. J Hosp Infect. 2001;49:289–292
  3. Weber DJ, Rutala WA, Blanchet CN, Jordan M, Gergen MF. Faucet aerators: a source of patient colonization with Stenotrophomonas maltophilia. Am J Infect Control. 1999;27:59–63
  4. Verweij PE, Meis JF, Christmann V, Van der Bor M, Melchers WJ, Hilderink BG, et al. Nosocomial outbreak of colonization and infection with Stenotrophomonas maltophilia in preterm infants associated with contaminated tap water. Epidemiol Infect. 1998;120:251–256
  5. Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 2008;17:R74
  6. Toleman MA, Bennett PM, Bennett DM, Jones RN, Walsh TR. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis. 2007;13:559–565
  7. Nicodemo AC, Garcia Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis. 2007;26:229–237
  8. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer and all causes in Japan: the Ohsaki study. JAMA. 2006;296:1255–1265
  9. Yoda Y, Hu ZQ, Zhao WH, Shimamura T. Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate. J Infect Chemother. 2004;10:55–58
  10. Osterburg A, Gardner J, Hyon SH, Neely A, Babcock G. Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG). Clin Microbiol Infect. 2009;15:341–346
  11. Andrews JM BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother. 2009;64:454–489
  12. Moriarty F, Elborn S, Tunney M. Development of a rapid colorimetric time–kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa. J Microbiol Methods. 2005;61:171–179
  13. Anand PK, Kaul D, Sharma M. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. Int J Biochem Cell Biol. 2006;38:600–609
  14. Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem Biophys Res Commun. 2006;347:401–405
  15. Ikigai H, Nakae T, Hara Y, Shimamura T. Bactericidal catechins damage the lipid bilayer. Biochim Biophys Acta. 1993;1147:132–136
  16. Gradisar H, Pristovsek P, Plaper A, Jerala R. Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J Med Chem. 2007;50:264–271
  17. Navarro-Martínez MD, Navarro-Perán E, Cabezas-Herrera J, Ruiz-Gómez J, García-Cánovas F, Rodríguez-López JN. Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2005;49:2914–2920
  18. Unno T, Kondo K, Itakura H, Takeo T. Analysis of (−)-epigallocatechin in human serum obtained after ingesting green tea. Biosci Biotechnol Biochem. 1996;60:2066–2068
  19. Javaid A, Bonkovsky HL. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern. J Hepatol. 2006;45:334–335
  20. Camouse MM, Domingo DS, Swain FR, Conrad EP, Matsui MS, Maes D, et al. Topical application of green and white tea extract provides protection from solar-simulated ultraviolet light in human skin. Exp Dermatol. 2009;18:522–526
  21. Kim H, Kawazoe T, Han DW, Matsumara K, Tsutsumi S, Hyon SH. Enhanced wound healing by an epigallocatechin-incorporated collagen sponge in diabetic mice. Wound Repair Regen. 2008;16:714–720
  22. Zhao WH, Asano N, Hu ZQ, Shimamura T. Restoration of antibacterial activity of β-lactams by epigallocatechin gallate against β-lactamase-producing species depending on location of β-lactamase. J Pharm Pharmacol. 2003;55:735–740
  23. Bernal P, Zloh M, Taylor PW. Disruption of d-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the β-lactam resistance modifier (−)-epicatechin gallate. J Antimicrob Chemother. 2009;63:1156–1162

PII: S0924-8579(10)00159-7

doi: 10.1016/j.ijantimicag.2010.03.025

International Journal of Antimicrobial Agents
Volume 36, Issue 2 , Pages 129-131 , August 2010

Article Tools

* Image Usage & Resolution